146 related articles for article (PubMed ID: 36284039)
1. Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma.
Babu D; Chintal R; Panigrahi M; Phanithi PB
Cell Oncol (Dordr); 2022 Dec; 45(6):1451-1465. PubMed ID: 36284039
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
3. EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.
Kapoor GS; Christie A; O'Rourke DM
Cancer Biol Ther; 2007 Apr; 6(4):571-9. PubMed ID: 17457042
[TBL] [Abstract][Full Text] [Related]
4. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.
Hall EH; Liu Y; Xiao A; Shock L; Brautigan DL; Mayo MW; Adusumilli PS; Jones DR
PLoS One; 2014; 9(4):e95869. PubMed ID: 24763730
[TBL] [Abstract][Full Text] [Related]
6. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
7. [DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis].
Xia J; Lü ZD; Zhou PH; Cui SC; Kong B; Liu D; Long SS; Zhang XH; Zhao JJ
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3483-3487. PubMed ID: 29275584
[No Abstract] [Full Text] [Related]
8. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
[TBL] [Abstract][Full Text] [Related]
10. Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.
Sheng XJ; Zhou YQ; Song QY; Zhou DM; Liu QC
Oncol Rep; 2012 Apr; 27(4):1011-8. PubMed ID: 22200669
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.
Vaidya KS; Sanchez JJ; Kim EL; Welch DR
Cancer Lett; 2009 Aug; 281(1):100-7. PubMed ID: 19307053
[TBL] [Abstract][Full Text] [Related]
12. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
13. Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
Yadav N; Babu D; Madigubba S; Panigrahi M; Phanithi PB
J Neurooncol; 2023 Jul; 163(3):675-692. PubMed ID: 37415005
[TBL] [Abstract][Full Text] [Related]
14. Cell surface area and membrane folding in glioblastoma cell lines differing in PTEN and p53 status.
Memmel S; Sukhorukov VL; Höring M; Westerling K; Fiedler V; Katzer A; Krohne G; Flentje M; Djuzenova CS
PLoS One; 2014; 9(1):e87052. PubMed ID: 24498019
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
Tanaka K; Babic I; Nathanson D; Akhavan D; Guo D; Gini B; Dang J; Zhu S; Yang H; De Jesus J; Amzajerdi AN; Zhang Y; Dibble CC; Dan H; Rinkenbaugh A; Yong WH; Vinters HV; Gera JF; Cavenee WK; Cloughesy TF; Manning BD; Baldwin AS; Mischel PS
Cancer Discov; 2011 Nov; 1(6):524-38. PubMed ID: 22145100
[TBL] [Abstract][Full Text] [Related]
17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
18. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
[TBL] [Abstract][Full Text] [Related]
19. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
Hurst DR; Xie Y; Vaidya KS; Mehta A; Moore BP; Accavitti-Loper MA; Samant RS; Saxena R; Silveira AC; Welch DR
J Biol Chem; 2008 Mar; 283(12):7438-44. PubMed ID: 18211900
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1.
Li J; Li G
Cancer Res; 2010 Dec; 70(24):10445-53. PubMed ID: 21056991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
